In summary, DCs can initiate antitumor immunity by inducing ferroptosis in cancer cells via the TCR–IFN-γ axis, yet their own ferroptosis, triggered by PPARγ activation, PD-L1 deficiency, or XBP1-driven lipid accumulation, abrogates antigen presentation and suppresses CD8+ T cell activity. Here, IFNG is linked to cancer.